Patents Represented by Attorney Marina Larson & Associates, LLC
  • Patent number: 7569551
    Abstract: Administration of antisense oligodeoxynucleotides (ODN) targeted against the testosterone-repressed prostate message-2 (TRPM-2) gene can reduce the amount of TRPM-2 in renal cell cancer (RCC) cells and other cancer cells, and as a result enhance chemosensitivity of these cells to chemotherapy agents and radiation. Thus, for example, the sensitivity of renal cell cancer cells to a chemotherapeutic agent can be increased by exposing renal cell cancer cells to a chemotherapeutic agent and an agent which reduces the amount of TRPM-2 in the renal cell cancer cells. This provides an improved method for treatment of renal cell cancer, which is generally resistant to treatment with known chemotherapy agents.
    Type: Grant
    Filed: September 28, 2001
    Date of Patent: August 4, 2009
    Assignee: The University of British Columbia
    Inventors: Martin Gleave, Paul S. Rennie, Hikeaki Miyake, Colleen Nelson, Tobias Zellweger
  • Patent number: 7534773
    Abstract: Antisense therapy which reduces the expression of TRPM-2 provides therapeutic benefits in the treatment of cancer for example prostate cancer and renal cell cancer. Antisense TRPM-2 ODN treatment of prostatic tumor cells in vivo is effective for delaying the onset of androgen independence and can be used in combination with androgen-withdrawal to induce apoptotic cell death of prostatic tumor cells in the individual. Combined use of antisense TRPM-2 and taxanes synergistically enhances cytotoxic chemosensitivity of androgen-independent prostate cancer. Radiation sensitivity is also enhanced when cells expressing TRPM-2 are treated with antisense TRPM-2 ODN. Thus, the antisense TRPM-2 ODNs can be used to enhance hormone sensitivity, chemosensitivity and radiation sensitivity of a variety of cancer types in which expression of TRPM-2 has been observed.
    Type: Grant
    Filed: February 25, 2000
    Date of Patent: May 19, 2009
    Assignee: The University of British Columbia
    Inventors: Martin Gleave, Paul S. Rennie, Hideaki Miyake, Colleen Nelson
  • Patent number: 7498400
    Abstract: Polycarbonates incorporating terminal carbonate groups derived from ester-substituted activated carbonates in a transesterification process have unfavorable properties with respect to color, hydrolytic stability and thermal stability, particularly when the polycarbonate containing such end groups is molded. The number of activated carbonate end groups formed during the melt transesterification formation of polycarbonate can be reduced by reacting a dihydroxy compound with an activated diaryl carbonate in the presence of an esterification catalyst to produce a polycarbonate, in the presence of a monohydroxy chainstopper such as para-cumyl phenol in an amount that results in 35 to 65 mol % of the end groups being derived from the monohydroxy chainstopper. Suitably, the reactants are provided such that the molar ratio of activated diaryl carbonate to the total of dihydroxy compound plus ½ the chainstopping reagent that is less than 1.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: March 3, 2009
    Assignee: Sabic Innovative Plastics IP B.V.
    Inventors: Bernd Jansen, Jan Henk Kamps, Edward Kung, Patrick Joseph McCloskey, Paul Michael Smigelski, Jr.
  • Patent number: 7488764
    Abstract: A pigment contains one or more substantially spherical-shaped beads. Each substantially spherical-shaped bead includes one or more high aspect ratio particles encapsulated within an encapsulating material. Resinous compositions containing this pigment and a plastic, for example a polycarbonate, have a flowline-free colored, sparkling and/or metallescent appearance.
    Type: Grant
    Filed: October 20, 2004
    Date of Patent: February 10, 2009
    Assignee: Sabic Innovative Plastics IP B.V.
    Inventors: Stanley Young Hobbs, Robert Edgar Colborn, Eelco M. S. van Hamersveld, Fazila Seker, Ali Ersin Acar, Chris Hartshorn, Daniel Steiger
  • Patent number: 7485694
    Abstract: Polycarbonate is prepared by reactive extrusion on a reactive extruder. A method incorporates the steps of introducing a polycarbonate oligomer, an activated carbonate residue, and a transesterification catalyst to the extruder through a feed section. The extruder has the feed section, a polycarbonate exit section, and a reaction section between the feed section and the polycarbonate exit section. The reaction section is made up of at least one conveying section, kneading sections, and venting sections. The configuration of the reaction section requires that at least one venting section be disposed between each pair of kneading sections, and that the kneading sections and venting sections are selected such that the number of venting sections minus the number of kneading sections is greater than or equal to one. The method further contains the step of extruding the reaction components at a temperature in a range between 100° C. and 500° C.
    Type: Grant
    Filed: December 21, 2005
    Date of Patent: February 3, 2009
    Assignee: Sabic Innovative Plastics IP B.V.
    Inventors: Peter Davis, Hans Looij
  • Patent number: 7485695
    Abstract: Polycarbonate is prepared by reactive extrusion on a reactive extruder. A method incorporates the steps of introducing a polycarbonate oligomer, an activated carbonate, and a transesterification catalyst to the extruder through a feed section. The extruder has a feed section, a polycarbonate exit section, and a reaction section between the feed section and the polycarbonate exit section. The reaction section has one or more devolatilization units, wherein each devolatilization unit incorporates an array of vent-conveying sections and conveying sections arranged in a configuration of: (C V C)x(V)n, and/or (V C V)x(C)n. (V) is a vent-conveying section, (C) is a conveying section, x is 1 or more, and n is 1 or 0. The extruder screw in the vent-conveying sections and the conveying sections in each devolatilization unit have conveying elements or conveying elements and mixing elements and no elements that create a melt seal in the devolatilization unit.
    Type: Grant
    Filed: September 6, 2006
    Date of Patent: February 3, 2009
    Assignee: Sabic Innovative Plastics IP B.V
    Inventors: Peter Davis, Hans Looij
  • Patent number: 7482423
    Abstract: Polycarbonates incorporating terminal carbonate groups derived from ester-substituted activated carbonates, for example terminal methyl salicyl carbonate (TMSC) derived from the use of BMSC as the activated carbonate in a transesterification process, have unfavorable properties with respect to color, hydrolytic stability and thermal stability, particularly when the polycarbonate containing such end groups is molded. The number of activated carbonate end groups formed during the melt transesterification formation of polycarbonate can be reduced, however, without sacrificing the benefits of using an activated diaryl carbonate, and without requiring a separate reaction or additional additives by reacting a dihydroxy compound with an activated diaryl carbonate in the presence of an esterification catalyst to produce a polycarbonate, wherein the molar ratio of activated diaryl carbonate to dihydroxy compound is less than 1 when expressed to at least three decimal places, for example 0.996 or less.
    Type: Grant
    Filed: June 30, 2006
    Date of Patent: January 27, 2009
    Assignee: Sabic Innovative Plastics IP B.V.
    Inventors: Bernd Jansen, Jan Henk Kamps, Edward Kung, Patrick Joseph McCloskey, Paul Michael Smigelski, Jr.
  • Patent number: 7470732
    Abstract: A pigment contains one or more substantially spherical-shaped beads. Each substantially spherical-shaped bead includes one or more high aspect ratio particles encapsulated within an encapsulating material. Resinous compositions containing this pigment and a plastic, for example a polycarbonate, have a flowline-free colored, sparkling and/or metallescent appearance.
    Type: Grant
    Filed: October 26, 2007
    Date of Patent: December 30, 2008
    Assignee: Sabic Innovative Plastics IP BV
    Inventors: Stanley Young Hobbs, Robert Edgar Colborn, Eelco M. S. van Hamersveld, Fazila Seker, Ali Ersin Acar, Chris Hartshorn, Daniel Steiger
  • Patent number: 7456418
    Abstract: A cementitious container that has a low-frequency radio tag containing the container's pedigree and history. The container is used for storage of hazardous waste are disclosed having an inner layer of substantially unhydrated cement in contact with the hazardous waste and an outer layer of hydrated cement. Cementitious hazardous waste containers may be prepared by compressing powdered hydraulic cement around solid hazardous waste materials as well as the encapsulated radio tag that uses low frequency communication. This makes it possible to read and write information though the wall of the container as during transportation to a storage site. Once placed at the storage site, the pedigree, (history contents, Chain of Possession, Proof of delivery, weight), may be checked and verified by reading the tag on a regular basis, (once an hour), to confirm the vessel is intact and has not been moved.
    Type: Grant
    Filed: November 14, 2005
    Date of Patent: November 25, 2008
    Assignee: Visible Assets, Inc
    Inventors: John K. Stevens, Paul Waterhouse, Jason August
  • Patent number: 7446190
    Abstract: Chimeric T cell receptors (TCR) are provided that combine, in a single chimeric species, the intracellular domain of CD3 ?-chain, a signaling region from a costimulatory protein such as CD28, and a binding element that specifically interacts with a selected target. When expressed, for example in T-lymphocytes from the individual to be treated for a condition associated with the selected target, a T cell immune response is stimulated in the individual to the target cells. The chimeric TCR's are able to provide both the activation and the co-stimulation signals from a single molecule to more effectively direct T-lymphocyte cytotoxicity against the selected target and T-lymphocyte proliferation.
    Type: Grant
    Filed: May 28, 2003
    Date of Patent: November 4, 2008
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Michel Sadelain, Renier Brentjens, John Maher
  • Patent number: 7438694
    Abstract: A lancing device is used with a lancet for lancing body tissue to result in a wound for bleeding. An improved lancing device has a priming knob having a slanted priming notch rotatably connected to the lancing device about an axis of rotation generally parallel to a central axis of the lancing device and a strike path of a lancet carrier. Rotation, translation, or both rotation and translation of the priming knob allows a user to prime the lancing device.
    Type: Grant
    Filed: March 7, 2006
    Date of Patent: October 21, 2008
    Assignee: Agamatrix, Inc.
    Inventors: Brad Boozer, Joseph Flaherty, Timothy Golnik
  • Patent number: 7439359
    Abstract: Structural differences in binding pockets of members of the HSP90 family can be exploited to achieve differential degradation of kinases and other signaling proteins through the use of designed small molecules which interact with the N-terminal binding pocket with an affinity which is greater than ADP and different from the ansamycin antibiotics for at least one species of the HSP90 family. Moreover, these small molecules can be designed to be soluble in aqueous media, thus providing a further advantage over the use of ansamycin antibiotics. Pharmaceutical compositions can be formulated containing a pharmaceutically acceptable carrier and a molecule that includes a binding moiety which binds to the N-terminal pocket of at least one member of the HSP90 family of proteins. Such binding moieties were found to have antiproliferative activity against tumor cells which are dependent on proteins requiring chaperones of the HSP90 family for their function.
    Type: Grant
    Filed: November 1, 2001
    Date of Patent: October 21, 2008
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Gabriela Chiosis, Neal Rosen
  • Patent number: 7436304
    Abstract: A system uses a large loop antenna, connected with a transceiver operating below 1 MHz. The loop antenna is deployed from a spool to surround a crime scene, and may carry indicia communicating that it is a crime scene boundary. The system interrogates devices, including evidence bags and badged personnel, as they enter and leave the scene. The system can optionally log the time of salient events. A second loop antenna can log evidence bags as they enter a vehicle. The devices can be silenced by the transceiver and thus collisions can be reduced and avoided among responses from devices. The system performs “area reads” that would not be possible if higher RF frequencies were employed.
    Type: Grant
    Filed: July 7, 2006
    Date of Patent: October 14, 2008
    Assignee: Visible Assets, Inc
    Inventors: Paul Waterhouse, John K Stevens, Jason August, Jessica L Olson
  • Patent number: 7429649
    Abstract: The present invention relates to the modification of lignin biosynthesis in plants, using the nucleotide sequences encoding the enzymes 4-coumarate CoA-ligase (4CL), cinnamoyl-CoA reductase (CCR), cinnamyl alcohol dehydrogenase (CAD) of the lignin biosynthetic pathway, from ryegrass (Lolium) and fescue (Festuca). The present invention also relates to regulatory elements, promoters capable of causing expression of exogenous genes in plants, wherein the regulatory elements are from the genes for caffeic acid Omethyl transferase (OMT), 4CL, CCR or CAD. The invention also relates to vectors including the nucleic acids and regulatory elements of the invention, plant cells, plants, plant seeds and other plant parts transformed with the regulatory elements, nucleic acids and vectors and methods using the nucleic acids, regulatory elements and vectors.
    Type: Grant
    Filed: June 14, 2001
    Date of Patent: September 30, 2008
    Assignees: Dairy Australia Limited, Molecular Plant Breeding Nominees Ltd.
    Inventors: German Carlos Spangenberg, Angela Jane Lidgett, Robyn Louise Heath, Russell Leigh McInnes, Damian Paul Lynch
  • Patent number: 7393896
    Abstract: An aromatic carbonate polymer composition having improved thermal stability consisting of an aromatic carbonate polymer such as a polycarbonate or polycarbonate/polyester blend and an impact modifier which is free of alkali materials which catalytically degrade a polycarbonate. Also an impact modifier which is preferably of a shell-core structure prepared by the emulsion polymerization process and has a pH of about 3 to about 8. A preferred emulsifier is an alkyl sulfonate having an alkyl group of C6-C18 carbons.
    Type: Grant
    Filed: April 4, 2003
    Date of Patent: July 1, 2008
    Inventors: James L. DeRudder, Robert R. Gallucci
  • Patent number: 7372277
    Abstract: An electrochemical cell has two terminals. One of the terminals is connected to a pulse-width-modulated (PWM) power supply and to a voltmeter. The other terminal is connected to circuitry capable of switching between amperometric and potentiometric measurement modes. A sequence of successive approximations permits selection of a PWM duty cycle giving rise to a desired voltage at the terminal connected with the power supply. In this way a stable excitation voltage is supplied to the cell even in the face of supply voltage instability or drift or instability in electronics coupled with the cell.
    Type: Grant
    Filed: April 15, 2005
    Date of Patent: May 13, 2008
    Assignee: Agamatrix, Inc.
    Inventors: Steven Diamond, Martin Forest, Baoguo Wei
  • Patent number: 7368436
    Abstract: It has been determined that antisense therapy which reduces the expression of TRPM-2 provides therapeutic benefits in the treatment of cancer, particularly prostate and renal cell cancers. Addition of antisense TRPM-2 ODN to prostatic tumor cells in vivo is effective for delaying the onset of androgen independence, thus prostate cancer can be treated by initiating androgen-withdrawal to induce apoptotic cell death of prostatic tumor cells in an individual, and administering a composition effective to inhibit expression of TRPM-2 by the tumor cells. Combined use of antisense TRPM-2 and taxanes synergistically enhances cytotoxic chemosensitivity of androgen-independent prostate cancer and in human Renal cell cancer. Radiation sensitivity is also enhanced when cells expressing TRPM-2 are treated with antisense TRPM-2 ODN.
    Type: Grant
    Filed: August 30, 2001
    Date of Patent: May 6, 2008
    Assignee: The University of British Columbia
    Inventors: Martin Gleave, Paul S. Rennie, Hideaki Miyake, Colleen Nelson
  • Patent number: 7365149
    Abstract: A surface of a melt polymerization reactor system having residual reaction components of a melt polymerization reaction thereon can be cleaned by introducing a cleaning agent having a phenolic compound to the polymerization reactor system and into contact with the surface of the melt polymerization reactor system having the residual reaction components of a melt polymerization reaction thereon. The residual reaction components of the melt polymerization reaction include polycarbonate oligomers or polymers or their degradation products. Further, the cleaning agent is maintained in contact with the surface for a period of time and at a temperature sufficient to substantially remove the residual reaction components from the surface.
    Type: Grant
    Filed: December 12, 2005
    Date of Patent: April 29, 2008
    Inventors: Hans-Peter Brack, Maarten Antoon Jan Campman, Laurus van der Wekke, Dennis James Patrick Maria Willemse
  • Patent number: 7345116
    Abstract: An optically clear thermoplastic resin composition is disclosed which comprises structural units derived from substituted or unsubstituted polycarbonate and substituted or unsubstituted polyester, wherein said polyester comprises structural units derived from terephthalic acid and a mixture of 1,4-cyclohexane dimethanol and ethylene glycol, wherein said ethylene glycol is greater than about 60 mole percent based on total moles of 1,4-cyclohexane dimethanol and ethylene glycol. In addition the composition disclosed possess good environmental stress cracking resistance, flow and thermal properties.
    Type: Grant
    Filed: July 13, 2006
    Date of Patent: March 18, 2008
    Inventors: Abbas-Alli Ghudubhai Shaikh, Manatesh Chakraborty, Manickam Jayakannan, Ganesh Kannan, Vishvajit Chandrakant Juikar, Rajashekhar Shiddappa Totad
  • Patent number: RE40697
    Abstract: This invention relates to an extrusion method preparing polycarbonates from a solution of an oligomeric polycarbonate. A mixture of bis(methyl salicyl)carbonate (BMSC), BPA and a transesterification catalyst are first equilibrated at moderate temperatures to provide a solution of polycarbonate oligomer in methyl salicylate. The solution is then fed to a devolatilizing extruder, where the polymerization reaction is completed and the methyl salicylate solvent is removed. The solution comprising the oligomeric polycarbonate can also be pre-heated under pressure to a temperature above the boiling point of methyl salicylate and subsequently fed to a devolatilizing extruder equipped for rapid flashing off the solvent. The method provides polycarbonate with greater efficiency than the corresponding process in which unreacted monomers are fed to the extruder. Additionally, the method of the invention does not require the isolation of a precursor polycarbonate comprising ester-substituted phenoxy terminal groups.
    Type: Grant
    Filed: January 31, 2006
    Date of Patent: April 7, 2009
    Assignee: Sabic Innovative Plastics IP B.V.
    Inventors: Norberto Silvi, Mark Howard Giammattei, Patrick Joseph McCloskey, Alberto Nisoli, James Day, Narayan Ramesh, Paul Michael Smigelski, Jr., Paul Russell Wilson